Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease

Behavioural Brain Research

Volumn 156, Issue 2, 2005, Pages 225-232

  Ognibene, Elisa ^a   Middei, Silvia ^b   Daniele, Stefania ^b   Adriani, Walter ^a   Ghirardi, Orlando ^b   Caprioli, Antonio ^b   Laviola, Giovanni ^a  

^a Section of Behavioural Neuroscience   (Italy)

^b Sigma Tau SpA   (Italy)

Author keywords

Alzheimer's disease; Cognitive deficit; Locomotor activity; Mouse models

Indexed keywords

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL SCIENCE; COGNITIVE DEFECT; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; SPATIAL MEMORY; TASK PERFORMANCE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; INHIBITION (PSYCHOLOGY); MAZE LEARNING; MEMORY; MICE; MICE, TRANSGENIC; POSTURE; SPATIAL BEHAVIOR; TIME FACTORS;

EID: 9644254315     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2004.05.028     Document Type: Article

References (57)

1. W. Adriani, A. Caprioli, O. Granstrem, M. Carli, and G. Laviola The spontaneously hypertensive-rat as an animal model of ADHD: evidence for impulsive and non-impulsive subpopulations Neurosci. Biobehav. Rev. 27 7 2003 639 651
2. W. Adriani, F. Sargolini, R. Coccurello, A. Oliverio, and A. Mele Role of dopaminergic system in reactivity to spatial and non-spatial changes in mice Psychopharmacology 150 67-76 2000
3. M. Ammassari-Teule, and A. Caprioli Spatial learning and memory, maze running strategies and cholinergic mechanisms in two inbred strains of mice Behav. Brain Res. 17 1 1985 9 16
4. G.W. Arendash, D.L. King, M.N. Gordon, D. Morgan, J.M. Hatcher, and C.E. Hope Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes Brain Res. 891 2001 42 53
5. D.C. Blanchard, R.J. Blanchard, P. Tom, and R.J. Rodgers Diazepam changes risk assessment in an anxiety/defense test battery Psychopharmacology (Berlin) 101 1990 511 518
6. P.F. Chapman, G.L. White, M.J. Jones, D. Cooper-Blacketer, V.J. Marshall, and M. Irizarry Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice Nat. Neurosci. 2 3 1999 271 276
7. P.F. Chapman, A.M. Falinska, S.G. Knevett, and M.F. Ramsay Genes, models and Alzheimer's disease Trends Genet. 17 2001 254 261
8. M.C. Chartier-Harlin, F. Crawford, H. Houlden, A. Warren, D. Hughes, and L. Fidani Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene Nature 353 6347 1991 844 846
9. G. Chen, K.S. Chen, J. Knox, J. Inglis, A. Bernard, and S.J. Martin A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease Nature 408 2000 975 979
10. J.A. Chung, and J.L. Cummings Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease Neurol. Clin. 18 2000 829 846
11. A.P.M. Cruz, F. Frei, and F.G. Graeff Ethopharmacological analysis of rat behavior on the elevated plus-maze Pharmacol. Biochem. Behav. 49 1994 171 176
12. K.R. Daffner, L.F.M. Scinto, S. Weintraub, J.E. Guinessey, and M.M. Mesulam Diminished curiosity in patients with probable Alzheimer's disease as measured by exploratory eye movements Neurology 42 1992 320 328
13. S.E. File Factors controlling measures of anxiety and responses to novelty in the mouse Behavioural Brain Res. 125 2001 151 157
14. S. Frautschy, F. Yang, M. Irrizarry, B. Hyman, T. Saido, and K. Hsiao Microglial response to amyloid plaques in APPsw transgenic mice Am. J. Pathol. 1998 307 317
15. D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette, and C. Blackwell Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein Nature 1995 523 527
16. M. Gordon, D. King, D. Diamond, P. Jantzen, K. Boyett, and C. Hope Correlation between working memory deficits and A β deposits in transgenic APP+PS1 mice Neurobiol. Aging 22 2001 377 385
17. L. Hendriks, C.M. van Duijn, P. Cras, M. Cruts, W. Van Hul, and F. van Harskamp Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene Nat. Genet. 1 3 1992 218 221
18. L. Holcomb, N. Gordon, P. Jantzen, K. Hsiao, K. Duff, and D. Morgan Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits Behav. Genet. 29 1999 177 185
19. L. Holcomb, M. Gordon, E. McGowan, X. Yu, S. Benkovic, and P. Jantzen Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Nat. Med. 1998 97 100
20. A. Holmes, and R.J. Rodgers Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze Neurosci. Biobehav. Rev. 23 1999 971 980
21. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, and S. Younkin Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
22. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 5284;274:99-105.
23. K.A. Hsiao Learning and memory in transgenic mice modeling Alzheimer's disease Learn Mem. 8 2001 301 308
24. M. Irizarry, F. Soriano, M. McNamara, K. Page, D. Schenk, and D. Games Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse J. Neurosci. 17 1997 7053 7059
25. M. Irizarry, M. McNamara, K. Fedorchack, K. Hsiao, and B. Hyman APPsw transgenic mice develop age-related Aβ deposits and neurophil abnormalities, but no neuronal loss in CA1 J. Neuropathol. Exp. Neurol. 1997 965 973
26. C. Janus, J. Pearson, J. McLaurin, P.M. Mathews, Y. Jiang, and S.D. Schmidt Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 408 2000 979 982
27. K. Johnson-Wood, M. Lee, R. Motter, K. Hu, G. Gordon, and R. Barbour Amyloid precursor protein processing and Aβ-42 deposition in a transgenic mouse model of Alzheimer disease Proc. Natl. Acad. Sci. 94 1997 1550 1555
28. T. Kawarabayashi, L.H. Younkin, T.C. Saido, M. Shoji, K.H. Ashe, and S.G. Younkin Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease J. Neurosci. 21 2001 372 381
29. D.L. King, and G.W. Arendash Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months Physiol. Behav. 75 2002 627 642
30. D.L. King, G.W. Arendash, F. Crawford, T. Sterk, J. Menendez, and M.J. Mullan Progressive and gender-dependent cognitive impairment in the APPsw transgenic mouse model for Alzheimer's disease Behav. Brain Res. 103 1999 145 162
31. M. Klingner, J. Apelt, A. Kumar, D. Sorger, O. Sabri, and J. Steinbach Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology Int. J. Dev. Neurosci. 21 7 2003 357 369
32. R. Lalonde The neurobiological basis of spontaneous alternation Neurosci. Biobehav. Rev. 26 2002 91 104
33. M.P. Lambert, A.K. Barlow, B.A. Chromy, C. Edwards, R. Freed, and M. Liosatos Diffusible, nonfibrillar ligands derived from Aβ-1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. 95 1998 6448 6453
34. G. Laviola, S. Macri, S. Morley-Fletcher, and W. Adriani Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence Neurosci. Biobehav. Rev. 27 1-2 2003 19 31
35. G. Laviola, W. Adriani, M.L. Terranova, and G. Gerra Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models Neurosci. Biobehav. Rev. 23 1999 993 1010
36. J. Lewis, D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, and G. Jones Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP Science 293 2001 1487 1491
37. R.G. Lister Ethologically-based animal models of anxiety disorders Pharmacol. Ther. 46 1990 321 340
38. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, and K. Beyreuther Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 46 1999 860 866
39. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, and L.M. Brownlee The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 4 1991 479 486
40. K. Mishima, T. Tozawa, K. Satoh, Y. Matsumoto, Y. Hishikawa, and M. Okawa Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking Biol. Psychiatry 45 1999 417 421
41. P.M. Moran, L.S. Higgins, B. Cordell, and P.C. Moser Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein Proc. Natl. Acad. Sci. U.S.A. 92 1995 5341 5345
42. J.C. Morris The Clinical Dementia Rating (CDR): Current version and scoring rules Neurology 43 1993 2412 2414
43. M. Mullan, and F. Crawford Genetic and molecular advances in Alzheimer's disease Trends Neurosci. 1993 183 188
44. J. Murrell, M. Farlow, B. Ghetti, and M.D. Benson A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease Science 254 5028 1991 97 99
45. M. Okawa, K. Mishima, Y. Hishikawa, S. Hozumi, H. Hori, and K. Takahashi Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment Sleep 14 1991 478 485
46. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J. Neurosci. Methods 14 1985 149 167
47. B. Poucet Object exploration, habituation, and response to spatial-change in rats following septal or medial frontal cortical damage Behav. Neurosci. 103 1989 1009 1016
48. R.J. Douglas W.N. Denber L.L. Richman Spontaneous alternation behavior 1990 Springer-Verlag New York 73 109
49. P. Roullet, and J. Lassalle Genetic variation, hippocampal mossy fibres distribution, novelty reactions and spatial representation in mice Behav. Brain Res. 1990 61 76
50. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, and T. Guido Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
51. D.L. Sparks, S.T. DeKosky, and W.R. Markesbery Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus Arch. Neurol. 45 1988 994 999
52. D.F. Swaab, E.J. Van Someren, J.N. Zhou, and M.A. Hofman Biological rhythms in the human life cycle and their relationship to functional changes in the suprachiasmatic nucleus Prog. Brain Res. 111 1996 349 368
53. R. Tanzi, D. Kovacs, T. Kim, R. Moir, S. Guenette, and W. Wasco The gene defects responsible for familial Alzheimer's disease Neurobiol. Dis. 3 1996 159 168
54. B. Tate, K.S. Aboody-Guterman, A.M. Morris, E.C. Walcott, R.E. Majocha, and C.A. Marotta Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid Proc. Natl Acad. Sci. U.S.A. 89 1992 7090 7094
55. C. Thinus-Blanc, M. Durup, and Poucet B The spatial parameters encoded by hamsters during exploration: a further study Behav. Proc. 26 1992 43 57
56. L. Volicer, D.G. Harper, B.C. Manning, R. Goldstein, and A. Satlin Sundowning and circadian rhythms in Alzheimer's disease Am. J. Psychiatry 158 2001 704 711
57. W. Witting, I.H. Kwa, P. Eikelenboom, M. Mirmiran, and D.F. Swaab Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease Biol. Psychiatry 27 1990 563 572